Similar observation from Eliquis ARISTOTLE trial, see Abstract: 4045 Events after discontinuation of randomized treatment at the end of the ARISTOTLE trial http://spo.escardio.org/SessionDetails.aspx?eevtid=54&sessId=9505&subSessId=0&searchQuery=%2fdefault.aspx%3feevtid%3d54%26days%3d%26topics%3d%26types%3d%26rooms%3d%26freetext%3dApixaban%2b%26sort%3d1%26page%3d1%26showResults%3dTrue%26nbPerPage%3d20%26scroll%3D534#.UDfkdNbiaJk
Market Data 
Markets
AI
